Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Expression profiles and functional prediction of histone acetyltransferases of the MYST family in kidney renal clear cell carcinoma

Fig. 3

Expression level of MYST HATs in KIRC. (A) MYST HAT mRNA levels in KIRC patient, **, P < 0.01; ***, P < 0.001. compared to normal tissues (UALCAN database) (B) Western blot analysis of MYST HATs in KIRC. KIRC tissue samples and adjacent non-cancerous tissue samples were obtained from 20 KIRC patients. The left band of each sample was adjacent non-cancerous tissue, and the right band of each sample was KIRC tissue. Actin was used as an internal control. The boxes marked in the figure have been cropped. Original blots were cut prior to hybridization with antibodies (see a detailed explanation in Additional File 2) (C) Relative expression analyses using densitometry intensity ratio of western blot bands. Student’s t-test, two paired, compared to adjacent non-cancerous tissue *, P < 0.05

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us